{
    "Trade/Device Name(s)": [
        "iHealth Wireless Smart Gluco-Monitoring System",
        "iHealth Gluco+"
    ],
    "Submitter Information": "Andon Health Co., Ltd.",
    "510(k) Number": "K181070",
    "Predicate Device Reference 510(k) Number(s)": [
        "K170231"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "February 1, 2019",
    "Summary Letter Received Date": "December 27, 2018",
    "Submission Date": "April 18, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iHealth Wireless Smart Glucose Meter (BG5S)",
        "iOS device",
        "Android device"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancet",
        "Lancing device"
    ],
    "Document Summary": "FDA 510(k) summary for iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+) for measuring blood glucose using an electrochemical biosensor.",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from multiple sites for self-testing by diabetics at home as an aid in monitoring diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}